Interestingly, most breast cancer subtypes expressed a high level of ZEB2 and low level of RAB25, except in claudin-low subtype in which RAB25 has been described as a tumor suppressor (Additional file 1: Fig. S1b). Here, ZEB2 is linked to breast carcinoma.